Riskpilot← Back to searchSign inGet full accessUPPSALA OFTALMOLOGI AB
ABActiveOrg 5591247282Medical specialists activities · NACE 8622Est. 20171 employees
Revenue 2024
SEK 2,8M
-50% vs 2023
EBITDA margin
63.2%
-42% vs 2023
Equity ratio
59.0%
Financial strength
Net profit 2024
SEK 2M
+15% vs 2023
| Revenue | SEK 2,8M | -50% |
| EBITDA | SEK 1,8M | -42% |
| Net profit | SEK 2M | +15% |
| Total assets | SEK 13,9M | -1% |
| Equity | SEK 8,2M | +18% |
| Employees | 1 | — |
Legal name
UPPSALA OFTALMOLOGI AB
Org number
5591247282
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 september 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Ögonläkartjänster, musikproduktion samt därmed förenlig verksamhet.
Address
Email
haverinen.mic@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 723 | 5 075 | 5 778 | 5 585 | 2 804 |
| Staff expenses | — | — | −2 393 | −2 245 | −834 |
| EBITDA | 1 940 | 2 698 | 3 228 | 3 041 | 1 771 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 1 940 | 2 698 | 3 228 | 3 041 | 1 771 |
| Net financials | −17 | −7 | −2 | −6 | −22 |
| Profit before tax | 1 437 | 2 014 | 2 416 | 2 260 | 2 628 |
| Tax | −313 | −419 | −501 | −483 | −581 |
| Net profit | 1 124 | 1 595 | 1 915 | 1 777 | 2 047 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 271 | 10 677 | 12 312 | 14 073 | 13 863 |
| Equity | 4 625 | 5 440 | 5 955 | 6 930 | 8 176 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 2 382 | 2 296 | 2 606 | 2 618 | 2 040 |
| Total debt | 2 382 | 2 296 | 2 606 | 2 618 | 2 040 |
EBITDA margin
63.2%
This company
15.8%
Market median
+300% vs market
20202024
Equity ratio
59.0%
This company
38.2%
Market median
+54% vs market
20202024
Return on equity
25.0%
This company
18.4%
Market median
+36% vs market
20202024
Net profit margin
73.0%
This company
8.1%
Market median
+801% vs market
20202024
Asset turnover
0.20×
This company
1.12×
Market median
-82% vs market
20202024
Debt / equity
0.70×
This company
0.62×
Market median
+13% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KF | Audit | 2022 |
PH Authorized Recipient of Service | Authorized Recipient of Service | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of UPPSALA OFTALMOLOGI AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Fredrik Agerson | Audit | 0 companies |
| Per Hugo Torstensson | Authorized Recipient of Service | 0 companies |
| Pär Gustav Alfred Hallberg | Deputy Board Member | 0 companies |
| Mikko-Ilkka Petteri Haverinen | Board of Directors | 0 companies |